Abstract |
This study evaluated efficacy and safety of growth hormone treatment in Duchenne muscular dystrophy boys with glucocorticoid-induced growth failure. We reviewed 39 consecutive boys (average age 11.5 years; 32 ambulatory) treated with growth hormone for 1 year during a four-year period. Boys were on long-term daily deflazacort or prednisone (mean duration 5 ± 2.2 years; dosing regimen prednisone 0.75 mg/kg/day equivalent). Primary outcomes were growth velocity and height-for-age z-scores (height SD) at 1 year. Height velocity increased from 1.3 ± 0.2 to 5.2 ± 0.4 cm/year on growth hormone (p<0.0001). Pre- growth hormone decline in height SD (-0.5 ± 0.2SD/year) stabilized at height SD -2.9 ± 0.2 on growth hormone (p<0.0001). The rate of weight gain was unchanged, at 2.8 ± 0.6 kg/year pre- growth hormone and 2.6 ± 0.7 kg/year at 1 year. Motor function decline was similar pre- growth hormone and at 1 year. Cardiopulmonary function was unchanged. Three experienced side effects. In this first comprehensive report of growth hormone in Duchenne muscular dystrophy, growth hormone improved growth at 1 year, without detrimental effects observed on neuromuscular and cardiopulmonary function.
|
Authors | Meilan M Rutter, James Collins, Susan R Rose, Jessica G Woo, Heidi Sucharew, Hemant Sawnani, Kan N Hor, Linda H Cripe, Brenda L Wong |
Journal | Neuromuscular disorders : NMD
(Neuromuscul Disord)
Vol. 22
Issue 12
Pg. 1046-56
(Dec 2012)
ISSN: 1873-2364 [Electronic] England |
PMID | 22967789
(Publication Type: Journal Article)
|
Copyright | Copyright © 2012 Elsevier B.V. All rights reserved. |
Chemical References |
- Glucocorticoids
- Pregnenediones
- Human Growth Hormone
- deflazacort
- Prednisone
|
Topics |
- Body Height
(drug effects)
- Body Weight
(drug effects)
- Child
- Glucocorticoids
(adverse effects, therapeutic use)
- Growth Disorders
(chemically induced)
- Human Growth Hormone
(adverse effects, therapeutic use)
- Humans
- Male
- Muscular Dystrophy, Duchenne
(drug therapy, physiopathology)
- Prednisone
(adverse effects, therapeutic use)
- Pregnenediones
(adverse effects, therapeutic use)
- Treatment Outcome
|